Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10651)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2021 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Buyco DG, Martin J, Jeon S, Hooks R, Lin C, Carr R. Experimental models of metabolic and alcoholic fatty liver disease. World J Gastroenterol 2021; 27(1): 1-18 [PMID: 33505147 DOI: 10.3748/wjg.v27.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i1/1.htm |
| Number | Citing Articles |
| 1 |
Chunyan Zhang, Yabin Zhao, Mengli Yu, Jianru Qin, Bingyu Ye, Qiwen Wang. Mitochondrial Dysfunction and Chronic Liver Disease. Current Issues in Molecular Biology 2022; 44(7): 3156 doi: 10.3390/cimb44070218
|
| 2 |
雯 郭. Research Progress of Porphyrin Metabolism in Fatty Liver Disease. Advances in Clinical Medicine 2024; 14(07): 321 doi: 10.12677/acm.2024.1472017
|
| 3 |
Zhewen Ren, Hans Bosma, Anke Wesselius, Simone J.P.M. Eussen, M. Eline Kooi, Carla J.H. van der Kallen, Annemarie Koster, Marleen M.J. van Greevenbroek, Pieter Dagnelie, Coen D.A. Stehouwer, Martijn C.G.J. Brouwers. Traditional lifestyle factors partly mediate the association of socioeconomic position with intrahepatic lipid content: The Maastricht study. JHEP Reports 2023; 5(11): 100855 doi: 10.1016/j.jhepr.2023.100855
|
| 4 |
Brisa Rodope Alarcón-Sánchez, Osiris Germán Idelfonso-García, Dafne Guerrero-Escalera, Carolina Piña-Vázquez, Guillermo de Anda-Jáuregui, José Luis Pérez-Hernández, Mireya de la Garza, Francisco García-Sierra, Yesennia Sánchez-Pérez, Rafael Baltiérrez-Hoyos, Verónica Rocío Vásquez-Garzón, Pablo Muriel, Julio Isael Pérez-Carreón, Saúl Villa-Treviño, Jaime Arellanes-Robledo. A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer. Biochemical Pharmacology 2024; 228: 116209 doi: 10.1016/j.bcp.2024.116209
|
| 5 |
You Wu, Minghui Wang, Tao Yang, Lingling Qin, Yaomu Hu, Dan Zhao, Lili Wu, Tonghua Liu, Alessandra Durazzo. Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/9561613
|
| 6 |
Shyam Patel, Rebecca G. Kim, Amy M. Shui, Catherine Magee, Maggie Lu, Jennifer Chen, Michele Tana, Chiung-Yu Huang, Mandana Khalili. Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those With Unhealthy Alcohol Use. Gastro Hep Advances 2024; 3(1): 84 doi: 10.1016/j.gastha.2023.09.012
|
| 7 |
Qing Li, Ronghong Pei, Erbao Chen, Fuping Zheng, Yuhang Zhang, Shihao Meng. Efficacy of Jiuzao polysaccharides in ameliorating alcoholic fatty liver disease and modulating gut microbiota. Heliyon 2024; 10(4): e26167 doi: 10.1016/j.heliyon.2024.e26167
|
| 8 |
Xi Le, Yin Zhang, Mei Yang, Jie Li, Hao Wang, Jin-Lin Wu, Juan Deng, Hong-Min Zhang. Effect of <i>Dendrobium nobile</i> powder combined with conventional therapy on mild to moderate fatty liver. World Journal of Gastroenterology 2024; 30(45): 4791-4800 doi: 10.3748/wjg.v30.i45.4791
|
| 9 |
Kyung-Hwan Jegal, Hye-Rim Park, Beom-Rak Choi, Jae-Kwang Kim, Sae-Kwang Ku. Synergistic Protective Effect of Fermented Schizandrae Fructus Pomace and Hoveniae Semen cum Fructus Extracts Mixture in the Ethanol-Induced Hepatotoxicity. Antioxidants 2023; 12(8): 1602 doi: 10.3390/antiox12081602
|
| 10 |
Marco Arrese, Juan P. Arab, Francisco Barrera, Benedikt Kaufmann, Luca Valenti, Ariel E. Feldstein. Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity. Seminars in Liver Disease 2021; 41(04): 421 doi: 10.1055/s-0041-1730927
|
| 11 |
Linlin Jiang, Qin Meng, Lixiu Liu, Weihang Li. A Comprehensive Review on Molecular Mechanisms, Treatments, and Brief Role of Natural Products in Hepatocellular Cancer. Natural Product Communications 2024; 19(9) doi: 10.1177/1934578X241284873
|
| 12 |
Liana Gheorghe, Speranta Iacob. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 133 doi: 10.1007/978-3-031-33548-8_12
|
| 13 |
Xiaoqin Wu, Laura E Nagy, Jérémie Gautheron. Mediators of necroptosis: from cell death to metabolic regulation. EMBO Molecular Medicine 2024; 16(2): 219 doi: 10.1038/s44321-023-00011-z
|
| 14 |
Josef Illek, Stanislav Veselskyi, Andrii Pototskyi, Viktoriia Gryshchenko, Yevdokiia Reshetnik. Bilirubin derivatives in bile, blood, and liver of rats upon correction of experimental fatty hepatosis. Ukrainian journal of veterinary sciences 2024; 15(2): 46 doi: 10.31548/veterinary2.2024.46
|
| 15 |
Riina Harjumäki, Chris S. Pridgeon, Magnus Ingelman-Sundberg. CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload. International Journal of Molecular Sciences 2021; 22(15): 8221 doi: 10.3390/ijms22158221
|
| 16 |
Yang Zheng, Yi-Hui Zheng, Jia-Hui Wang, Tie-Jian Zhao, Lei Wang, Tian-Jian Liang. Progress of mitochondrial and endoplasmic reticulum-associated signaling and its regulation of chronic liver disease by Chinese medicine. World Journal of Hepatology 2024; 16(4): 494-505 doi: 10.4254/wjh.v16.i4.494
|
| 17 |
Delfin Gerard Buyco, Joseph L. Dempsey, Eleonora Scorletti, Sookyoung Jeon, Chelsea Lin, Julia Harkin, Susovon Bayen, Emma E. Furth, Jasmin Martin, Monique Delima, Royce Hooks, Jaimarie Sostre-Colón, Sina A. Gharib, Paul M. Titchenell, Rotonya M. Carr, Md. Wasim Khan. Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism. PLOS ONE 2023; 18(5): e0281954 doi: 10.1371/journal.pone.0281954
|
| 18 |
Rotonya M. Carr. DDS Perspective: Time to Get Serious About the Global Pandemic. Digestive Diseases and Sciences 2022; 67(10): 4616 doi: 10.1007/s10620-022-07628-z
|
| 19 |
Damien Chua, Zun Siong Low, Guo Xiang Cheam, Aik Seng Ng, Nguan Soon Tan. Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm. International Journal of Molecular Sciences 2022; 23(23): 14762 doi: 10.3390/ijms232314762
|
| 20 |
Tatiana V. Brus, Anna A. Kalinina, Anastasia A. Bannova, Rodion V. Korablev, Yurii S. Brus. Influence of non-alcoholic fatty liver disease on reproductive function in an experiment. Pediatrician (St. Petersburg) 2024; 15(1): 37 doi: 10.17816/PED15137-44
|
| 21 |
Qing Li, Liling Wu, Guangnan Wang, Fuping Zheng, Jinyuan Sun, Yuhang Zhang, Zexia Li, Lianghao Li, Baoguo Sun. Inhibitory Effects of Jiuzao Polysaccharides on Alcoholic Fatty Liver Formation in Zebrafish Larvae and Their Regulatory Impact on Intestinal Microbiota. Foods 2024; 13(2): 276 doi: 10.3390/foods13020276
|
| 22 |
Rui Liu, Yun-Tao Hao, Na Zhu, Xin-Ran Liu, Rui-Xue Mao, Jia-Wei Kang, Chao Hou, Ting Zhang, Yong Li. Walnut (Juglans regia L.) Oligopeptides Alleviate Alcohol-Induced Acute Liver Injury through the Inhibition of Inflammation and Oxidative Stress in Rats. Nutrients 2023; 15(9): 2210 doi: 10.3390/nu15092210
|
| 23 |
Syeda Hoorulain Ahmed, Abdul Moeed, Eisha Waqar, Sahar Rizwan, Nimra Hasnain, Mohammad Aadil Qamar, Kaneez Fatima, Abdul Mannan Khan Minhas. Efficacy of sodium-glucose co-transporter 2 inhibitors in treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Obesity Medicine 2022; 33: 100437 doi: 10.1016/j.obmed.2022.100437
|
| 24 |
Yuqing Cheng, Shuangzhe Lin, Tianyi Ren, Jianbin Zhang, Yingying Shi, Yingwei Chen, Yuanwen Chen. New murine model of alcoholic hepatitis in obesity-induced metabolic-associated fatty liver disease. Experimental Animals 2023; 72(3): 389 doi: 10.1538/expanim.22-0160
|